Clinical Edge Journal Scan

Can proximal serrated polyp detection rate serve as an indicator for interval post-colonoscopy CRC?


 

Key clinical point: The proximal serrated polyp (PSP) detection rate (DR) of an endoscopist is inversely associated with the incidence of interval post-colonoscopy colorectal cancer (CRC) and should be universally adopted as a separate quality indicator alongside adenoma DR (ADR) to accelerate CRC prevention.

Major finding: With each percentage point increase in PSP DR, the adjusted interval post-colonoscopy CRC rate reduced by 7% (adjusted hazard ratio 0.93; P < .0001).

Study details: This was a population-based study including patients aged 55-76 years with a positive fecal immunochemical test who underwent a colonoscopy; the data of 277,555 colonoscopies were included in the PSP DR calculations.

Disclosures: The study did not receive any funding. A few authors declared serving as speakers or advisory board members or receiving consulting fees or research grants from various sources.

Source: van Toledo DEFWM et al. Serrated polyp detection and risk of interval post-colonoscopy colorectal cancer: a population-based study. Lancet Gastroenterol Hepatol. 2022 (May 9). Doi: 10.1016/S2468-1253(22)00090-5

Recommended Reading

Radical surgery improves survival in older patients with gastric cancer
MDedge Hematology and Oncology
CRC screening: Blood test accuracy compared to colonoscopy
MDedge Hematology and Oncology
Alarming increase in esophageal cancer in middle-aged adults
MDedge Hematology and Oncology
Metastatic CRC: Phase 3 supports extension of sequential treatment over combination
MDedge Hematology and Oncology
KEYNOTE-177 delivers final results with pembrolizumab vs chemotherapy for MSI-H or dMMR mCRC
MDedge Hematology and Oncology
Unresectable mCRC: Final survival outcomes with first-line trifluridine/tipiracil plus bevacizumab in TASCO1
MDedge Hematology and Oncology
Proton pump inhibitors curb capecitabine efficacy in stage II-III CRC
MDedge Hematology and Oncology
Proton pump inhibitors curb capecitabine efficacy in stage II-III CRC
MDedge Hematology and Oncology
Survival after CRS-HIPEC in synchronous vs metachronous peritoneal metastasis of CRC
MDedge Hematology and Oncology
Can proximal serrated polyp detection rate serve as an indicator for interval post-colonoscopy CRC?
MDedge Hematology and Oncology